Orthofix Medical Inc. (OFIX)
USD 14.56
(-6.34%)
USD 14.56
(-6.34%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 326.58 Million USD | 168.2% |
| 2022 | 121.76 Million USD | -12.83% |
| 2021 | 139.68 Million USD | -17.34% |
| 2020 | 168.99 Million USD | 0.6% |
| 2019 | 167.98 Million USD | 28.0% |
| 2018 | 131.24 Million USD | 20.69% |
| 2017 | 108.74 Million USD | 0.11% |
| 2016 | 108.62 Million USD | -1.17% |
| 2015 | 109.91 Million USD | 17.48% |
| 2014 | 93.55 Million USD | -19.29% |
| 2013 | 115.91 Million USD | 10.21% |
| 2012 | 105.18 Million USD | -72.35% |
| 2011 | 380.38 Million USD | 25.5% |
| 2010 | 303.09 Million USD | -13.45% |
| 2009 | 350.2 Million USD | -2.49% |
| 2008 | 359.15 Million USD | -20.49% |
| 2007 | 451.72 Million USD | -3.82% |
| 2006 | 469.65 Million USD | 347.39% |
| 2005 | 104.97 Million USD | -21.62% |
| 2004 | 133.92 Million USD | -22.32% |
| 2003 | 172.4 Million USD | 302.59% |
| 2002 | 42.82 Million USD | -1.52% |
| 2001 | 43.48 Million USD | -11.11% |
| 2000 | 48.92 Million USD | 23.78% |
| 1999 | 39.52 Million USD | 9.18% |
| 1998 | 36.2 Million USD | -16.01% |
| 1997 | 43.1 Million USD | -5.07% |
| 1996 | 45.4 Million USD | 6.82% |
| 1995 | 42.5 Million USD | 300.94% |
| 1994 | 10.6 Million USD | -1.85% |
| 1993 | 10.8 Million USD | 33.33% |
| 1992 | 8.1 Million USD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q2 | 335.99 Million USD | 0.08% |
| 2024 Q1 | 335.73 Million USD | 2.8% |
| 2023 Q3 | 290.16 Million USD | 11.05% |
| 2023 Q1 | 252.97 Million USD | 107.75% |
| 2023 FY | 326.58 Million USD | 168.2% |
| 2023 Q2 | 261.3 Million USD | 3.29% |
| 2023 Q4 | 326.58 Million USD | 12.55% |
| 2022 Q4 | 121.76 Million USD | 4.86% |
| 2022 Q1 | 126.41 Million USD | -9.5% |
| 2022 FY | 121.76 Million USD | -12.83% |
| 2022 Q2 | 119.71 Million USD | -5.31% |
| 2022 Q3 | 116.12 Million USD | -3.0% |
| 2021 Q1 | 159.05 Million USD | -5.88% |
| 2021 Q4 | 139.68 Million USD | 3.04% |
| 2021 Q3 | 135.56 Million USD | -2.98% |
| 2021 FY | 139.68 Million USD | -17.34% |
| 2021 Q2 | 139.72 Million USD | -12.15% |
| 2020 Q3 | 162.23 Million USD | -35.28% |
| 2020 Q1 | 138.12 Million USD | -17.78% |
| 2020 Q2 | 250.66 Million USD | 81.48% |
| 2020 Q4 | 168.99 Million USD | 4.17% |
| 2020 FY | 168.99 Million USD | 0.6% |
| 2019 Q3 | 169.16 Million USD | 19.97% |
| 2019 Q1 | 135.63 Million USD | 3.34% |
| 2019 FY | 167.98 Million USD | 28.0% |
| 2019 Q4 | 167.98 Million USD | -0.7% |
| 2019 Q2 | 141.01 Million USD | 3.97% |
| 2018 Q1 | 95.83 Million USD | -11.88% |
| 2018 Q4 | 131.24 Million USD | 3.49% |
| 2018 Q2 | 121.91 Million USD | 27.22% |
| 2018 Q3 | 126.81 Million USD | 4.02% |
| 2018 FY | 131.24 Million USD | 20.69% |
| 2017 Q3 | 100.99 Million USD | 11.31% |
| 2017 FY | 108.74 Million USD | 0.11% |
| 2017 Q1 | 87.61 Million USD | -19.35% |
| 2017 Q2 | 90.73 Million USD | 3.56% |
| 2017 Q4 | 108.74 Million USD | 7.68% |
| 2016 Q2 | 106.5 Million USD | 22.0% |
| 2016 Q3 | 102.87 Million USD | -3.41% |
| 2016 FY | 108.62 Million USD | -1.17% |
| 2016 Q4 | 108.62 Million USD | 5.59% |
| 2016 Q1 | 87.3 Million USD | -20.57% |
| 2015 Q4 | 109.91 Million USD | 4.44% |
| 2015 Q1 | 96.17 Million USD | 2.8% |
| 2015 FY | 109.91 Million USD | 17.48% |
| 2015 Q3 | 105.24 Million USD | 15.05% |
| 2015 Q2 | 91.47 Million USD | -4.88% |
| 2014 Q2 | 128.78 Million USD | 27.15% |
| 2014 Q3 | 106.02 Million USD | -17.67% |
| 2014 Q1 | 101.28 Million USD | -12.63% |
| 2014 FY | 93.55 Million USD | -19.29% |
| 2014 Q4 | 93.55 Million USD | -11.76% |
| 2013 FY | 115.91 Million USD | 10.21% |
| 2013 Q3 | 111 Million USD | -2.82% |
| 2013 Q2 | 114.22 Million USD | 12.86% |
| 2013 Q1 | 101.21 Million USD | -3.78% |
| 2013 Q4 | 115.91 Million USD | 4.43% |
| 2012 Q1 | 369.17 Million USD | -2.94% |
| 2012 Q3 | 187.46 Million USD | -5.85% |
| 2012 Q4 | 105.18 Million USD | -43.89% |
| 2012 FY | 105.18 Million USD | -72.35% |
| 2012 Q2 | 199.1 Million USD | -46.07% |
| 2011 Q4 | 380.38 Million USD | 10.21% |
| 2011 FY | 380.38 Million USD | 25.5% |
| 2011 Q3 | 345.13 Million USD | -1.14% |
| 2011 Q2 | 349.11 Million USD | -1.44% |
| 2011 Q1 | 354.2 Million USD | 16.86% |
| 2010 Q4 | 303.09 Million USD | -0.87% |
| 2010 Q2 | 314.21 Million USD | -3.66% |
| 2010 FY | 303.09 Million USD | -13.45% |
| 2010 Q1 | 326.15 Million USD | -6.87% |
| 2010 Q3 | 305.75 Million USD | -2.69% |
| 2009 Q2 | 354.13 Million USD | 2.52% |
| 2009 Q3 | 361.49 Million USD | 2.08% |
| 2009 Q4 | 350.2 Million USD | -3.12% |
| 2009 FY | 350.2 Million USD | -2.49% |
| 2009 Q1 | 345.41 Million USD | -3.82% |
| 2008 Q1 | 456.59 Million USD | 1.08% |
| 2008 Q2 | 447.55 Million USD | -1.98% |
| 2008 Q4 | 359.15 Million USD | -2.65% |
| 2008 Q3 | 368.93 Million USD | -17.57% |
| 2008 FY | 359.15 Million USD | -20.49% |
| 2007 FY | 451.72 Million USD | -3.82% |
| 2007 Q1 | 469.26 Million USD | -0.08% |
| 2007 Q2 | 477.56 Million USD | 1.77% |
| 2007 Q3 | 488.43 Million USD | 2.28% |
| 2007 Q4 | 451.72 Million USD | -7.52% |
| 2006 Q3 | 504.46 Million USD | 608.15% |
| 2006 FY | 469.65 Million USD | 347.39% |
| 2006 Q2 | 71.23 Million USD | 3.47% |
| 2006 Q1 | 68.85 Million USD | -34.41% |
| 2006 Q4 | 469.65 Million USD | -6.9% |
| 2005 Q1 | 122.79 Million USD | -8.31% |
| 2005 Q4 | 104.97 Million USD | -22.6% |
| 2005 Q2 | 109.52 Million USD | -10.81% |
| 2005 Q3 | 135.63 Million USD | 23.83% |
| 2005 FY | 104.97 Million USD | -21.62% |
| 2004 Q3 | 148.91 Million USD | -8.07% |
| 2004 Q4 | 133.92 Million USD | -10.06% |
| 2004 Q2 | 161.97 Million USD | -2.35% |
| 2004 Q1 | 165.87 Million USD | -3.78% |
| 2004 FY | 133.92 Million USD | -22.32% |
| 2003 Q2 | 39.27 Million USD | -0.63% |
| 2003 Q1 | 39.52 Million USD | -7.69% |
| 2003 Q4 | 172.4 Million USD | 377.31% |
| 2003 FY | 172.4 Million USD | 302.59% |
| 2003 Q3 | 36.12 Million USD | -8.04% |
| 2002 Q2 | 37.05 Million USD | -9.92% |
| 2002 Q4 | 42.82 Million USD | 3.45% |
| 2002 FY | 42.82 Million USD | -1.52% |
| 2002 Q3 | 41.39 Million USD | 11.71% |
| 2002 Q1 | 41.13 Million USD | -5.4% |
| 2001 Q2 | 41.5 Million USD | 0.8% |
| 2001 FY | 43.48 Million USD | -11.11% |
| 2001 Q4 | 43.48 Million USD | 0.0% |
| 2001 Q1 | 41.17 Million USD | -15.83% |
| 2000 FY | 48.92 Million USD | 23.78% |
| 2000 Q1 | 52.14 Million USD | 31.94% |
| 2000 Q2 | 49.39 Million USD | -5.28% |
| 2000 Q3 | 46.45 Million USD | -5.94% |
| 2000 Q4 | 48.92 Million USD | 5.3% |
| 1999 Q4 | 39.52 Million USD | -0.7% |
| 1999 Q2 | 38.9 Million USD | -1.77% |
| 1999 Q3 | 39.8 Million USD | 2.31% |
| 1999 FY | 39.52 Million USD | 9.18% |
| 1999 Q1 | 39.6 Million USD | 9.39% |
| 1998 Q4 | 36.2 Million USD | 0.0% |
| 1998 FY | 36.2 Million USD | -16.01% |
| 1997 FY | 43.1 Million USD | -5.07% |
| 1997 Q4 | 43.1 Million USD | 0.0% |
| 1996 Q4 | 45.4 Million USD | 0.0% |
| 1996 FY | 45.4 Million USD | 6.82% |
| 1995 Q4 | 42.5 Million USD | 0.0% |
| 1995 Q1 | 13.1 Million USD | 23.58% |
| 1995 FY | 42.5 Million USD | 300.94% |
| 1994 Q4 | 10.6 Million USD | 0.0% |
| 1994 Q2 | 12.7 Million USD | 0.0% |
| 1994 FY | 10.6 Million USD | -1.85% |
| 1993 FY | 10.8 Million USD | 33.33% |
| 1993 Q4 | 10.8 Million USD | 0.0% |
| 1992 Q4 | 8.1 Million USD | 0.0% |
| 1992 FY | 8.1 Million USD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Accelerate Diagnostics, Inc. | 51.25 Million USD | -537.189% |
| BrainsWay Ltd. | 15.31 Million USD | -2032.591% |
| Cerus Corporation | 144.3 Million USD | -126.317% |
| Envoy Medical, Inc. | 9.4 Million USD | -3373.569% |
| electroCore, Inc. | 8.94 Million USD | -3551.034% |
| Helius Medical Technologies, Inc. | 5.34 Million USD | -6013.534% |
| IceCure Medical Ltd | 4.24 Million USD | -7589.781% |
| Inogen, Inc. | 121.38 Million USD | -169.056% |
| OrthoPediatrics Corp. | 72.56 Million USD | -350.083% |
| Lucid Diagnostics Inc. | 29.58 Million USD | -1004.036% |
| Monogram Orthopaedics, Inc. | 3.18 Million USD | -10163.697% |
| MaxCyte, Inc. | 36.1 Million USD | -804.492% |
| NeuroOne Medical Technologies Corporation | 1.84 Million USD | -17573.209% |
| Nexalin Technology, Inc. | 425.28 Thousand USD | -76692.756% |
| PAVmed Inc | 57.13 Million USD | -471.582% |
| Rapid Micro Biosystems, Inc. | 25.46 Million USD | -1182.586% |
| RxSight, Inc. | 22.18 Million USD | -1371.899% |
| Sight Sciences, Inc. | 46.43 Million USD | -603.301% |
| SI-BONE, Inc. | 61.05 Million USD | -434.947% |
| TELA Bio, Inc. | 59.16 Million USD | -451.972% |
| Treace Medical Concepts, Inc. | 113.96 Million USD | -186.556% |
| Vivos Therapeutics, Inc. | 10.31 Million USD | -3064.89% |
| Acutus Medical, Inc. | 54.83 Million USD | -495.534% |
| Talis Biomedical Corporation | 29.22 Million USD | -1017.523% |
| Spectral AI, Inc. | 12.4 Million USD | -2533.538% |
| Nano-X Imaging Ltd. | 23.13 Million USD | -1311.71% |
| CVRx, Inc. | 39.28 Million USD | -731.386% |
| DIH Holding US, Inc. Warrants | 11.95 Million USD | -2631.083% |
| PetVivo Holdings, Inc. | 2.42 Million USD | -13343.585% |
| Bioventus Inc. | 589.79 Million USD | 44.627% |
| Venus Concept Inc. | 107.1 Million USD | -204.926% |
| TriSalus Life Sciences, Inc. | 51.66 Million USD | -532.145% |
| LivaNova PLC | 1.15 Billion USD | 71.649% |
| 908 Devices Inc. | 37.49 Million USD | -771.126% |
| Alphatec Holdings, Inc. | 703.48 Million USD | 53.576% |
| Nemaura Medical Inc. | 26.37 Million USD | -1138.123% |
| NeuroPace, Inc. | 86.99 Million USD | -275.398% |
| LENSAR, Inc. | 22.4 Million USD | -1357.383% |
| Apyx Medical Corporation | 52.31 Million USD | -524.231% |
| Cutera, Inc. | 518.12 Million USD | 36.967% |
| STRATA Skin Sciences, Inc. | 29.32 Million USD | -1013.56% |
| BioSig Technologies, Inc. | 4.68 Million USD | -6870.864% |
| Anika Therapeutics, Inc. | 58.36 Million USD | -459.537% |
| ClearPoint Neuro, Inc. | 21.48 Million USD | -1419.848% |
| Integra LifeSciences Holdings Corporation | 2.19 Billion USD | 85.115% |
| Axonics, Inc. | 82.35 Million USD | -296.538% |
| Outset Medical, Inc. | 190.91 Million USD | -71.063% |
| IRIDEX Corporation | 24.91 Million USD | -1210.849% |
| PROCEPT BioRobotics Corporation | 123.96 Million USD | -163.449% |
| IRadimed Corporation | 20.73 Million USD | -1474.971% |
| Tivic Health Systems, Inc. | 1.67 Million USD | -19409.259% |
| INVO Bioscience, Inc. | 19.99 Million USD | -1533.336% |
| Telesis Bio, Inc. | 40.87 Million USD | -699.024% |
| Viemed Healthcare, Inc. | 40.79 Million USD | -700.645% |
| Varex Imaging Corporation | 668.6 Million USD | 51.154% |
| Quipt Home Medical Corp. | 136.29 Million USD | -139.62% |
| Inspira Technologies Oxy B.H.N. Ltd. | 3.57 Million USD | -9042.917% |
| Pulmonx Corporation | 60.63 Million USD | -438.599% |
| Dynatronics Corporation | 11.78 Million USD | -2672.341% |
| Modular Medical, Inc. | 2.27 Million USD | -14274.34% |
| ReShape Lifesciences Inc. | 4.06 Million USD | -7936.048% |
| Semler Scientific, Inc. | 6.27 Million USD | -5108.692% |
| InMode Ltd. | 75.91 Million USD | -330.204% |
| Bruker Corporation | 2.83 Billion USD | 88.487% |
| Cytosorbents Corporation | 29.98 Million USD | -989.144% |
| DexCom, Inc. | 4.19 Billion USD | 92.217% |
| Align Technology, Inc. | 2.45 Billion USD | 86.688% |
| Viveve Medical, Inc. | 10.84 Million USD | -2910.832% |
| ZimVie Inc. | 795.85 Million USD | 58.964% |
| Movano Inc. | 5.97 Million USD | -5368.603% |
| Cytek Biosciences, Inc. | 104.6 Million USD | -212.208% |
| Nexalin Technology, Inc. | 425.28 Thousand USD | -76692.756% |
| DIH Holdings US, Inc. Class A Common Stock | 11.95 Million USD | -2631.083% |
| Tandem Diabetes Care, Inc. | 639.02 Million USD | 48.893% |
| Profound Medical Corp. | 12.66 Million USD | -2478.466% |
| Insulet Corporation | 1.85 Billion USD | 82.399% |
| enVVeno Medical Corporation | 2.43 Million USD | -13312.115% |
| Surmodics, Inc. | 65.82 Million USD | -396.156% |
| iCAD, Inc. | 8 Million USD | -3981.803% |
| Nuwellis, Inc. | 6.78 Million USD | -4716.888% |
| Biotricity, Inc. | 35.91 Million USD | -809.215% |
| iRhythm Technologies, Inc. | 223.04 Million USD | -46.42% |
| Aethlon Medical, Inc. | 2.47 Million USD | -13070.609% |
| InspireMD, Inc. | 8.14 Million USD | -3911.116% |
| PAVmed Inc. | 57.13 Million USD | -471.582% |
| BIOLASE, Inc. | 35.34 Million USD | -823.914% |
| Beyond Air, Inc. | 29.77 Million USD | -996.843% |
| FONAR Corporation | 57.45 Million USD | -468.393% |
| AxoGen, Inc. | 101.16 Million USD | -222.834% |
| Vivani Medical, Inc. | 25.03 Million USD | -1204.462% |
| Tactile Systems Technology, Inc. | 87.79 Million USD | -271.982% |
| Inari Medical, Inc. | 209.32 Million USD | -56.018% |
| UFP Technologies, Inc. | 118.04 Million USD | -176.661% |
| QT Imaging Holdings, Inc. | 12.69 Million USD | -2473.462% |
| Heart Test Laboratories, Inc. | 2.18 Million USD | -14841.129% |
| Tenon Medical, Inc. | 5.56 Million USD | -5766.445% |
| Autonomix Medical, Inc. Common Stock | 1.77 Million USD | -18257.785% |
| Co-Diagnostics, Inc. | 17.63 Million USD | -1752.007% |
| AdaptHealth Corp. | 3.15 Billion USD | 89.643% |
| Sintx Technologies, Inc. | 6.59 Million USD | -4853.511% |
| NanoVibronix, Inc. | 2.68 Million USD | -12058.786% |
| Quanterix Corporation | 78.08 Million USD | -318.248% |
| Inspira Technologies Oxy B.H.N. Ltd. | 3.57 Million USD | -9042.917% |
| Sensus Healthcare, Inc. | 4.88 Million USD | -6585.466% |
| Pacific Biosciences of California, Inc. | 1.04 Billion USD | 68.739% |
| TransMedics Group, Inc. | 568.84 Million USD | 42.588% |
| ReWalk Robotics Ltd. | 16.68 Million USD | -1857.709% |
| NeuroMetrix, Inc. | 1.33 Million USD | -24397.721% |
| Hyperfine, Inc. | 9.8 Million USD | -3232.5% |
| Establishment Labs Holdings Inc. | 250.24 Million USD | -30.506% |
| Biomerica, Inc. | 2.66 Million USD | -12163.8% |
| Bone Biologics Corporation | 831.4 Thousand USD | -39181.238% |
| AVITA Medical, Inc. | 19.86 Million USD | -1543.989% |
| Bluejay Diagnostics, Inc. | 1.97 Million USD | -16446.983% |
| Silk Road Medical, Inc | 114.15 Million USD | -186.082% |